Urigen N.A. Appoints Terry M. Nida To Chief Operating Officer
11/29/2006 12:03:00 PM
BURLINGAME, Calif.--(BUSINESS WIRE)--Urigen N.A., Inc. has promoted Terry M. Nida to Chief Operating Officer.
Mr. Nida, aged 58, has 25 years of management experience in the pharmaceutical industry. Since May 2006, he has served as Vice President of Worldwide Sales, Marketing and Corporate Development at Urigen. Prior to joining Urigen, he held the position of Vice President at VIVUS Inc., a pharmaceutical company dedicated to the development and commercialization of therapeutic products, where he was responsible for worldwide corporate development, sales and marketing. Prior to Vivus, Mr. Nida served as Senior Director of Worldwide Sales, Marketing and Business Development for Centocor, Inc., a leader in monoclonal antibody production and technology and a wholly owned subsidiary of Johnson & Johnson. His past work experience also includes positions in sales and marketing at Bristol Laboratories, a division of Bristol Myers, and a distinguished military career.
comments powered by